Fluvastatin and the Breast Cancer Risk: A Meta-analysis of Observational Studies

Fluvastatin and the Breast Cancer Risk: A Meta-analysis of Observational Studies

Multiple studies have investigated the associations between fluvatatin and the risk of breast cancer (BC), but their results were conflicting. A meta-analysis of observational studies published regarding this subject was conducted in the present study. It aims to estimate the associations between fl...

Full description

Bibliographic Details
Main Authors:	Dong-Mei Liu, Jian Zhang, Wei Zhang, James Lu, Jian-Lun Han, Guang-Jun Hao, Sheng-Ming Ye
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2016-11-01
Series:	World Journal of Traditional Chinese Medicine
Subjects:	Fluvastatin Breast cancer Meta-analysis
Online Access:	http://www.wjtcm.org:8080/ch/reader/create_pdf.aspx?file_no=20150025&year_id=2016&quarter_id=1&flag=1

Similar Items

A COMPARISON BETWEEN FLUVASTATIN AND LOVASTATIN EFFECTS IN IRANIAN PATIENTS WITH HYPERCHOLESTEROLEMIA
by: S. Moradm, et al.
Published: (1998-08-01)

A COMPARISON BETWEEN FLUVASTATIN AND LOVASTATIN EFFECTS IN IRANIAN PATIENTS WITH HYPERCHOLESTEROLEMIA
by: S. Moradm, et al.
Published: (1998-12-01)

Development and validation of a GC-FID assay for determination of fluvastatin in pharmaceutical preparations
by: Serap Saglik Aslan, et al.
Published: (2009-01-01)

Detrimental effects of fluvastatin on plasma lipid metabolism in rat breast carcinoma model
by: Kapinová Andrea, et al.
Published: (2013-01-01)

Evaluate the efficacy of Simvastatin and Fluvastatin in patients with hypercholesterolemia and their effect on liver functions
by: Hassan A. H. Ali, et al.
Published: (2017-12-01)

Repurposing of Fluvastatin as an Anticancer Agent against Breast Cancer Stem Cells via Encapsulation in a Hyaluronan-Conjugated Liposome
by: Ji Su Yu, et al.
Published: (2020-11-01)

Fluvastatin Prevents Lung Adenocarcinoma Bone Metastasis by Triggering Autophagy
by: Zuozhang Yang, et al.
Published: (2017-05-01)

New HPLC method for determination of fluvastatin anti-hyperlipidemic drug in bulk and pharmaceutical dosage using simvastatin as internal standard
by: Safwan Ashour, et al.
Published: (2023-07-01)

Simvastatin and fluvastatin attenuate trauma-induced cell death and catabolism in human cartilage
by: Jana Riegger, et al.
Published: (2022-09-01)

Effects of Fluvastatin on Characteristics of Stellate Ganglion Neurons in a Rabbit Model of Myocardial Ischemia
by: Li-Jun Cheng, et al.
Published: (2016-01-01)

Protective Effects of Fluvastatin on Reproductive Function in Obese Male Rats Induced by High-Fat Diet through Enhanced Signaling of mTOR
by: Xiangrong Cui, et al.
Published: (2017-02-01)

Fluvastatin use and risk of acute pancreatitis: a population-based case-control study in Taiwan
by: Liao Kuan-Fu, et al.
Published: (2017-09-01)

Mastoparan, a Peptide Toxin from Wasp Venom Conjugated Fluvastatin Nanocomplex for Suppression of Lung Cancer Cell Growth
by: Nabil A. Alhakamy, et al.
Published: (2021-12-01)

Atorvastatin and Fluvastatin Potentiate Blood Pressure Lowering Effect of Amlodipine through Vasorelaxant Phenomenon
by: Niaz Ali, et al.
Published: (2023-05-01)

Inhibition of Orbivirus Replication by Fluvastatin and Identification of the Key Elements of the Mevalonate Pathway Involved
by: Fauziah Mohd Jaafar, et al.
Published: (2021-07-01)

A Combination of Low Doses of Fluvastatin and Valsartan Decreases Arterial Stiffness in Patients After Myocardial Infarction: A Pilot Study
by: Jurij Hanžel, et al.
Published: (2015-12-01)

Fluvastatin promotes chondrogenic differentiation of adipose-derived mesenchymal stem cells by inducing bone morphogenetic protein 2
by: Masanari Kuwahara, et al.
Published: (2022-08-01)

QUALITY OF LIFE AND COMPLIANCE TO THERAPY IN PATIENTS FOLLOWING SUCCESSFULTRANSLUMINAL CORONARY ANGIOPLASTY, WHO WERE PRESCRIBED FLUVASTATIN EXTENDED RELEASE ADDED TO STANDARD THERAPY. PROTOCOL OF THE OPEN-LABEL OBSERVATIONAL STUDY
by: A. V. Susekov, et al.
Published: (2016-01-01)

Fluvastatin Reduces Glucose Tolerance in Healthy Young Individuals Independently of Cold Induced BAT Activity
by: Martina Felder, et al.
Published: (2021-11-01)

Cytotoxic and Pro-Apoptotic Effects of a Sub-Toxic Concentration of Fluvastatin on OVCAR3 Ovarian Cancer Cells After its Optimized Formulation to Melittin Nano-Conjugates
by: Shaimaa M. Badr-Eldin, et al.
Published: (2021-02-01)

QUALITY OF LIFE AND COMPLIANCE TO THERAPY IN PATIENTS FOLLOWING SUCCESSFUL TRANSLUMINAL CORONARY ANGIOPLASTY, WHO WERE PRESCRIBED LESCOL XL (FLUVASTATIN) ADDED TO STANDARD THERAPY. RESULTS OF THE LESQOL OPEN-LABEL OBSERVATIONAL STUDY
by: A. V. Susekov, et al.
Published: (2016-01-01)

Role of Fluvastatin sodium loaded polymeric nanoparticles in the treatment of Hyperlipidemia: Fabrication and Characterization
by: Avinash S Gudigennavar, et al.
Published: (2023-01-01)

EFFECTS OF THERAPY ON THE ABILITY OF ERYTHROCYTES FLUVASTATIN AGGREGATION IN HYPERTENSIVE PATIENTS WITH DYSLIPIDEMIA
by: I. N. Medvedev, et al.
Published: (2012-03-01)

Optimized Conjugation of Fluvastatin to HIV-1 TAT Displays Enhanced Pro-Apoptotic Activity in HepG2 Cells
by: Lamya H. Al-Wahaibi, et al.
Published: (2020-06-01)

Modulation of Ion Channels in the Superior Cervical Ganglion Neurons by Myocardial Ischemia and Fluvastatin Treatment
by: Lijun Cheng, et al.
Published: (2018-09-01)

Statin's role on blood pressure levels: Meta‐analysis based on randomized controlled trials
by: Hui Ting Liu, et al.
Published: (2023-03-01)

Development, Statistical Optimization and Characterization of Fluvastatin Loaded Solid Lipid Nanoparticles: A 3<sup>2</sup> Factorial Design Approach
by: Afzal Haq Asif, et al.
Published: (2022-03-01)

Fluvastatin in the therapy of acute coronary syndrome: Rationale and design of a multicenter, randomized, double-blind, placebo-controlled trial (The FACS Trial)[ISRCTN81331696]
by: Slaby Josef, et al.
Published: (2005-03-01)

Diversity of Solid Forms Promoted by Ball Milling: Characterization and Intrinsic Dissolution Studies of Pioglitazone Hydrochloride and Fluvastatin Sodium Drug–Drug Systems
by: Marco Villeda-Villegas, et al.
Published: (2023-05-01)

Optimized combinations of statins and azoles against Acanthamoeba trophozoites and cysts in vitro
by: Ines Sifaoui, et al.
Published: (2019-01-01)

Spectrophotometric method for simultaneous determination of valsartan and substances from the group of statins in binary mixtures
by: Stolarczyk Mariusz, et al.
Published: (2017-12-01)

Assessing the Interactions of Statins with Human Adenylate Kinase Isoenzyme 1: Fluorescence and Enzyme Kinetic Studies
by: Magdalena Wujak, et al.
Published: (2021-05-01)

In Vitro Activity of Statins against <i>Naegleria fowleri</i>
by: Aitor Rizo-Liendo, et al.
Published: (2019-08-01)

Interferon‐γ‐induced HLA Class II expression on endothelial cells is decreased by inhibition of mTOR and HMG‐CoA reductase
by: Akihiro Maenaka, et al.
Published: (2020-05-01)

The Synergistic Effect of Fluvastatin and IFN-λ on Peripheral Blood Mononuclear Cells of Chronic Hepatitis C Virus (HCV) Patients with IL-28B rs12979860 CC Genotype
by: Amin Farzanegan Gharabolagh, et al.
Published: (2019-10-01)

Gene signature associated with resistance to fluvastatin chemoprevention for breast cancer
by: Anjana Bhardwaj, et al.
Published: (2022-03-01)

Statin Therapy Negatively Impacts Skeletal Muscle Regeneration and Cutaneous Wound Repair in Type 1 Diabetic Mice
by: Irena A. Rebalka, et al.
Published: (2017-12-01)

Statin Therapy Alters Lipid Storage in Diabetic Skeletal Muscle.
by: Irena A Rebalka, et al.
Published: (2016-07-01)

Bayesian statistic methods and theri application in probabilistic simulation models
by: Orietta Zaniolo, et al.
Published: (2006-03-01)

Association between aberrant APC promoter methylation and breast cancer pathogenesis: a meta-analysis of 35 observational studies
by: Dan Zhou, et al.
Published: (2016-07-01)